APO-LURASIDONE lurasidone hydrochloride 80 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-lurasidone lurasidone hydrochloride 80 mg film-coated tablet blister pack

arrotex pharmaceuticals pty ltd - lurasidone hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: hypromellose; maize starch; mannitol; croscarmellose sodium; magnesium stearate; titanium dioxide; macrogol 8000; iron oxide yellow; indigo carmine aluminium lake - apo-lurasidone is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

APO-LURASIDONE lurasidone hydrochloride 40 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-lurasidone lurasidone hydrochloride 40 mg film-coated tablet blister pack

arrotex pharmaceuticals pty ltd - lurasidone hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: hypromellose; maize starch; mannitol; croscarmellose sodium; magnesium stearate; titanium dioxide; macrogol 8000 - apo-lurasidone is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

APO-LURASIDONE lurasidone hydrochloride 20 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-lurasidone lurasidone hydrochloride 20 mg film-coated tablet blister pack

arrotex pharmaceuticals pty ltd - lurasidone hydrochloride, quantity: 20 mg - tablet, film coated - excipient ingredients: hypromellose; maize starch; mannitol; croscarmellose sodium; magnesium stearate; titanium dioxide; macrogol 8000 - apo- lurasidone is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

LURASIDONE SANDOZ lurasidone hydrochloride 80 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

lurasidone sandoz lurasidone hydrochloride 80 mg film-coated tablet blister pack

sandoz pty ltd - lurasidone hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: hypromellose; maize starch; mannitol; croscarmellose sodium; magnesium stearate; titanium dioxide; macrogol 8000; iron oxide yellow; indigo carmine aluminium lake - lurasidone sandoz is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

LURASIDONE SANDOZ lurasidone hydrochloride 40 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

lurasidone sandoz lurasidone hydrochloride 40 mg film-coated tablet blister pack

sandoz pty ltd - lurasidone hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: hypromellose; maize starch; mannitol; croscarmellose sodium; magnesium stearate; titanium dioxide; macrogol 8000 - lurasidone sandoz is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

LURASIDONE LUPIN lurasidone hydrochloride 20 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

lurasidone lupin lurasidone hydrochloride 20 mg film-coated tablet blister pack

lupin australia pty limited - lurasidone hydrochloride, quantity: 20 mg - tablet, film coated - excipient ingredients: hypromellose; mannitol; magnesium stearate; croscarmellose sodium; titanium dioxide; macrogol 6000 - lurasidone lupin is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

LURASIDONE LUPIN lurasidone hydrochloride 40 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

lurasidone lupin lurasidone hydrochloride 40 mg film-coated tablet blister pack

lupin australia pty limited - lurasidone hydrochloride, quantity: 40 mg - tablet, film coated - excipient ingredients: hypromellose; croscarmellose sodium; magnesium stearate; mannitol; titanium dioxide; macrogol 6000 - lurasidone lupin is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

LURASIDONE LUPIN lurasidone hydrochloride 80 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

lurasidone lupin lurasidone hydrochloride 80 mg film-coated tablet blister pack

lupin australia pty limited - lurasidone hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: mannitol; hypromellose; magnesium stearate; croscarmellose sodium; titanium dioxide; iron oxide yellow; macrogol 6000; indigo carmine aluminium lake - lurasidone lupin is indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

PHARMACOR LURASIDONE lurasidone hydrochloride 80 mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor lurasidone lurasidone hydrochloride 80 mg film-coated tablet blister pack

pharmacor pty ltd - lurasidone hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; lactose monohydrate; magnesium stearate; citric acid; pregelatinised maize starch; mannitol; povidone; titanium dioxide; hypromellose; iron oxide yellow; brilliant blue fcf aluminium lake; macrogol 400 - lurasidone hydrochloride film-coated tablets are indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).

PHARMACOR LURASIDONE lurasidone hydrochloride 80 mg film-coated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor lurasidone lurasidone hydrochloride 80 mg film-coated tablet bottle

pharmacor pty ltd - lurasidone hydrochloride, quantity: 80 mg - tablet, film coated - excipient ingredients: citric acid; croscarmellose sodium; povidone; pregelatinised maize starch; mannitol; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; iron oxide yellow; brilliant blue fcf aluminium lake; macrogol 400 - lurasidone hydrochloride film-coated tablets are indicated for the treatment of schizophrenia in adults and adolescents (aged 13 to 17 years).